Latest Updates

26th Mar 2020
 Companies urged to prioritize safety, paid leave and the maintenance of business and employment relationships to support communities and the markets as global pandemic unfolds. NEW YORK,...
Read more
24th Mar 2020
Our organizations recognize the extraordinary circumstances facing our world and deeply appreciate the ramifications to our companies and our communities during the current COVID-19 pandemic crisis. We urge all companies and shareholders to follow...
Read more
28th Feb 2020
 Mercy Investment Services, Boston Trust Walden and other investors have been actively involved for a number of years urging major investment firms to improve their proxy voting records especially on shareholder resolutions focused on climate change...
Read more
25th Feb 2020
Investors say proposals citing health and safety risks to workers, liabilities related to third-party sellers, and due diligence around the sale of surveillance tech, among other issues, indicate the company is failing to adequately...
Read more
12th Feb 2020
Report names JPMorgan “the world’s worst banker of climate change”. WEDNESDAY, FEBRUARY 12TH, 2020– Investors in JPMorgan ($JPM) who filed...
Read more
6th Feb 2020
As of Monday’s deadline for public comments on the SEC’s proposed restriction on shareholder rights, a broad group of investors has weighed in strongly against the SEC’s proposal to limit shareholders’ rights to file proposals for shareholders to...
Read more
22nd Nov 2019
Investor letter argues the companies are actively opposing standards that are good for business, shareholders, consumers, and the environment. NEW YORK, NY, FRIDAY, NOVEMBER 22, 2019 – In a letter...
Read more
18th Nov 2019
Report delivered at request of shareholders exposes serious lapses in human rights policies and a failure to demonstrate ‘respect for our inmates and detainees’. NEW YORK, NY, Monday,...
Read more
14th Nov 2019
2020 Shareholder Proposals at AbbVie, Amgen, Biogen Eli Lilly and Pfizer Ask for Study to Determine Feasibility of Incorporating Drug Pricing Risks into Exec Incentive Structures. NEW YORK...
Read more
5th Nov 2019
Agency caves to pressure from trade associations like the Business Roundtable, U.S. Chamber, and National Association of Manufacturers to the detriment of shareholders and the public interest....
Read more


Sign Up for our eNewsletter

* indicates required